Terms: = Thyroid cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Prognosis
5 results:
1. Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center.
Yu N; Duan L; Hu F; Yang S; Liu J; Chen M; Yao Y; Deng K; Feng F; Lian X; Mao X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1197244. PubMed ID: 37324275
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of DNA methylation and lymph node metastasis in papillary thyroid carcinoma.
Zhao F; Zhu S; Fang J; Dong H; Zhu C
Head Neck; 2023 Jul; 45(7):1654-1662. PubMed ID: 37097909
[TBL] [Abstract] [Full Text] [Related]
3. MiR-128-3p suppresses breast cancer cellular progression via targeting LIMK1.
Zhao J; Li D; Fang L
Biomed Pharmacother; 2019 Jul; 115():108947. PubMed ID: 31078043
[TBL] [Abstract] [Full Text] [Related]
4. [Study on the mechanism of miR-497-induced laryngeal squamous cell carcinoma growth inhibition by targeting cdk6].
Niu JT; Liu SG; Yan P; Li C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 54(2):126-132. PubMed ID: 30776865
[No Abstract] [Full Text] [Related]
5. Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer.
Fiore E; Giustarini E; Mammoli C; Fragomeni F; Campani D; Muller I; Pinchera A; Giani C
J Endocrinol Invest; 2007 Oct; 30(9):734-8. PubMed ID: 17993764
[TBL] [Abstract] [Full Text] [Related]
